CanSino Biologics Inc

Common Name
CanSino Biologics
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,115
Ticker
688185
Exchange
SHANGHAI STOCK EXCHANGE
Description
CanSino Biologics Inc. is a biotechnology company focused on developing, manufacturing, and commercializing high-quality vaccines for public health. Founded in Tianjin, China, the company is known for...

CanSino Biologics's Climate Target Data Preview

As of 2024, CanSino Biologics has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into CanSino Biologics ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Intensity-based Target*
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Square Meter (m2)
Copy restricted. Please purchase to unlock this data.
a
2030
*. This target is limited in scope and does not represent the company's full operational or organizational boundaries
Download CanSino Biologics's Climate Targets data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind CanSino Biologics’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CanSino Biologics’s data sources below and access millions more through our Disclosure Search.

a. CanSino Biologics's ESG Report 2024
Trace every data point back to CanSino Biologics’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into CanSino Biologics's Greenhouse Gas Emissions Pathways

As of 2024, CanSino Biologics has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions. a

Does CanSino Biologics have a target to reduce the emissions from its operations?

As of 2024, CanSino Biologics has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources. a

CanSino Biologics's most ambitious operational target is to reduce these emissions by 10% by 2030, compared to a baseline of 0.46 Metric Tonnes of CO2 equivalent (mtCO2e) per Square Meter (m2) in 2023. a

Instead of reducing operational emissions, CanSino Biologics has increased them, with 2024 levels exceeding those of the 2023 baseline, placing the company well behind its reduction target. a

CanSino Biologics's Operational (Scope 1+2) Emissions Pathway

20232024203000.150.30.450.6Current (+-0%)
Want Full Access to CanSino Biologics's Climate Targets Dataset?
Sign Up